GGrantIndex
← Leaderboards

Hospital For Sick Children, The

Compare ↔
$8,044,240
Total funding
11
Grants

Funding over time

peak $2.7M · FY201024
$5M$3.8M$2.5M$1.3M$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24

Funding mix

By agency

DOD$8,044,240 · 11

By mechanism

$8,044,240 · 11

Investigators at Hospital For Sick Children, The

InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).

Rising Stars

First grant in the last 5 yrs

Not enough data

Emerging Leaders

6–10 yrs in

Not enough data

All-Time

Most funded here, all years

Not enough data

Largest grants

PHYSICAL, PSYCHOLOGICAL, FINANCIAL LATE EFFECTS AND HEALTH CARE USE IN SURVIVORS OF ADOLESCENT AND YOUNG ADULT CANCER: A POPULATION-BASED STUDY$1,434,497
· FY2022 · Defense Health Agency
INTEGRATING A NATURAL HISTORY REGISTRY AND BIOBANK FOR CONSTITUTIONAL MISMATCH REPAIR DEFICIENCY (CMMRD): ADVANCING KNOWLEDGE AND THERAPEUTIC STRATEGIES$1,236,001
· FY2024 · Defense Health Agency
DEVELOPMENT OF NEW THERAPEUTICS TARGETING BIOFILM FORMATION BY THE OPPORTUNISTIC PULMONARY PATHOGENS PSEUDOMONAS AERUGINOSA AND ASPERGILLUS FUMIGATUS$964,569
· FY2016 · Department of the Army
DEVELOPMENT OF A BIOBANK FOR RARE PEDIATRIC EYE CANCERS$917,325
· FY2022 · Defense Health Agency
MODELING AND TARGETING METASTATIC DRIVERS IDENTIFIED IN SLEEPING BEAUTY SCREENS AND CODING FOR CYTOPLASMIC SIGNALING PROTEINS$832,769
· FY2016 · Department of the Army
APOBEC3, A HIT-AND-RUN DRIVER RESPONSIBLE FOR BREAST CANCER INITIATION AND/OR PROGRESSION?$695,251
· FY2024 · Defense Health Agency
DEFINING THE ROLE OF AND MECHANISM BY WHICH THE CHLORIDE CHANNEL CLIC1 REGULATES BRAIN TUMOR GROWTH$590,400
· FY2017 · Department of the Army
THE IMPACT OF CHILDHOOD-ONSET LUPUS ON THE DEVELOPING BRAIN$524,090
· FY2020 · Defense Health Agency
MOLECULAR-TARGETED THERAPIES OF CHILDHOOD CHOROID PLEXUS CARCINOMA$405,344
· FY2010 · Department of the Army
LONGITUDINAL CLINICAL AND MOLECULAR PROFILING TO IMPROVE OUTCOMES IN CHILDHOOD-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS$299,994
· FY2022 · Defense Health Agency
DISCOVERY OF NOVEL DRUGS TO IMPROVE BONE HEALTH IN NEUROFIBROMATOSIS TYPE 1: THE WNT/BETA-CATENIN PATHWAY IN FRACTURE REPAIR AND PSEUDARTHROSIS$144,000
· FY2013 · Department of Defense